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ABSTRACT
The hygiene hypothesis implies, in immunological terms, that microbial stimulation in early life skews the im-
mune system towards the development of a T helper type 1 (Th1)-type lymphocyte population, and away from
a T helper type 2 (Th2)-type development that is associated with atopy. The hygiene hypothesis originally theo-
rized that increased infections protected against atopy. This theory has evolved since harmful infections may
not be as critical as exposure to microbial burden because exposure to microbes can occur in the absence of
infections . Despite substantial public hygiene measures in modern metropolitan communities , an atopy-
protective effect of endotoxin in these metropolitan environments still occurs. This article is a review of clinical
and experimental studies concerning the protective effect of endotoxin exposure on the susceptibility to atopic
responses. The discussion includes : (1) factors influencing household endotoxin levels ; (2) recent develop-
ments in the potential use of endotoxin for the prevention of atopy and asthma ; (3) association of endotoxin
and pets with atopic sensitization and diseases ; (4) animal studies on the protective effects of timing of endo-
toxin exposure on atopy and asthma and (5) animal studies on the protective effects of endotoxin dose on
atopy and asthma．
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INTRODUCTION
The prevalence of atopic diseases in children is in-
creasing steadily in high-income countries. Changes
in environmental and life style factors probably play
an important role in this phenomenon. However, the
underlying mechanisms for this phenomenon remain
unknown. The so-called “hygiene hypothesis ” pro-
poses that limited exposure to microbes during early
childhood causes an insufficient stimulation of T
helper type 1 (Th1) cells, which is unable to counter-
balance an expansion of T helper type 2 (Th2) cells
and subsequently causes a predisposition to atopy.
This theory has recently attracted much scientific in-
terest.1,2
The hygiene hypothesis originally theorized that
an increased past history of infections protected
against atopy. Over time, this theory has evolved in
part due to evidence that harmful infections may not
be as critical as exposure to microbial burden. This
stems from the fact that exposure to microbes can oc-
cur in the absence of infections,1,2 since viable and
non-viable components of microorganisms are distrib-
uted in varying concentrations in domestic environ-
ments. The present review will concentrate on epide-
miological and experimental studies that examine the
protective effect of endotoxin exposure on the sus-
ceptibility to atopic responses．
ENDOTOXIN AND INNATE IMMUNITY
Endotoxin, a lipopolysaccharide (LPS), comprises the
majority of the outer layer of the outer cell membrane
in all gram-negative bacteria . Its potent immune
stimulatory capacity is largely attributed to the lipid A
moiety , which is highly conserved across bacterial
species. Endotoxin and other bacterial products, such
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Fig. 1　Bacterial DNA and endotoxin content in dust samples from 4 diferent locales: (1) 
urban homes in Denver, Colo; (2) rural homes in India; (3) farm homes in the United 
States; and (4) US farm barns. Bacterial DNA was measured with qRT PCR assay. Endo-
toxin was measured with LAL assay. Bacterial DNA and endotoxin levels in dust samples 
difered significantly by locale (P < 0.001)(Ref. 7). Results are expressed as means ± SD 
(n = 8).
Endotoxin (EU/mg dust)Bacterial DNA (µg DNA/g dust)
0
10
20
30
40
50
60
Denver Home Rural Home Farm Home Farm Barn
1000
2000
3000
4000
5000
0
Bacterial DNA
Endotoxin
as peptidoglycan, lipoteichoic acid, outer-membrane
lipoproteins, flagellin, and DNA cytosine-phosphate-
guanine (CpG ) motifs , activate innate immunity ,
which is closely linked to host defenses and secon-
dary adaptive immune responses. This process is me-
diated through Th1-type immune development. The
potential of inducers of Th1-type cytokines including
interleukin (IL)-12 and interferon (IFN)-γ like endo-
toxin and other bacterial components that abrogate
Th2-mediated responses before its onset has been es-
tablished.1,3,4
Members of the Toll-like receptor (TLR) family are
essential components in this immune process.5 Ten
TLRs (TLR1-10) have been identified in mammals
and the current paradigm dictates that individual
TLRs have distinct ligands. For example, (1) TLR4 is
a receptor for endotoxin, (2) TLR2 controls cellular
responsiveness to a variety of bacterial cell-wall com-
ponents that include peptidoglycan, lipoteichoic acid,
and outer-membrane lipoproteins, (3) TLR5 mediates
bacterial flagellin-induced cell activation and (4) TLR
9 acts with DNA CpG-motifs at the cell surface. Mem-
bers of the TLR family have some common structural
features including an extracellular domain consisting
of a signal peptide, multiple leucine-rich repeats, and
a cysteine-rich domain, followed by a transmembrane
region and cytoplasmic TollIL-1-receptor (TIR) do-
main. In general, the signaling pathway used by TIR
domain-containing proteins includes MyD 88, IL-1
receptor-associate kinase (IRAK), and tumor necrosis
factor (TNF) receptor-associated factor 6 (TRAF6).
Although it is known that signaling through TLRs is
required for adaptive Th1 responses, it is unclear if
TLRs are needed for Th2 priming．
ENDOTOXIN AND THE DOMESTIC ENVI-
RONMENT
Endotoxins are ubiquitous in our environment. The
exposure levels in our homes are below those found
in the occupational environment. However, the litera-
ture contains reports to investigate the convenient
measurable nature of endotoxin in home environ-
ments and illness associated with exposures. In con-
trast, bacterial products other than endotoxin in the
domestic environment have not been widely re-
ported. It should be noted that coexistence of high
levels of endotoxin and other bacterial components in
dust samples might raise fascinating possibilities of
synergy with regard to immune modulatory , atopy-
protective, or proinflammatory effects．
FACTORS INFLUENCING METROPOLITAN
ENDOTOXIN LEVELS
Some studies have shown the presence of higher
amounts of endotoxin in farm and rural homes com-
pared with metropolitan sites.6,7 Recently, Roy et al.7
measured endotoxin and bacterial DNA levels in dust
samples from four different settings : farm barns and
farm homes in the United States, rural homes in In-
dia, and urban homes in Denver. Endotoxin and bac-
terial DNA levels in dust samples differed signifi-
cantly by setting, with highest levels in farm barn
samples and lowest levels in urban homes (Fig. 1). A
correlation between bacterial by-products with a
trend towards lower levels in urban homes is consis-
tent with the hygiene hypothesis and indicates that
endotoxin may be a good marker of bacterial load in
environments where dust samples are collected．
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Fig. 2　Corelations between concentrations of house-dust 
endotoxin and proportions of interferon-γ-producing CD4 
and CD8 T lymphocytes (Ref 15).
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House dust endotoxin levels in metropolitan
homes probably vary greatly. However, there is insuf-
ficient information available to explain how environ-
mental and lifestyle factors influence endotoxin levels
in house dust from metropolitan homes . Gereda
et al.8 showed that homes with dogs and cats in met-
ropolitan Denver had significantly higher levels of
house dust endotoxin, and Fel d 1 and Can f 1 levels
had a positive correlative trend with house dust endo-
toxin levels. In contrast, there was a negative correla-
tion between household Fel d 1 and endotoxin levels
in homes without dogs and cats. Therefore, factors
that influence allergen and endotoxin levels in house
dust were different in homes without animals. They
also reported several home conditions not associated
with endotoxin levels in house dust. These conditions
included type of building, season of dust sample col-
lection , home dampness , number of home inhabi-
tants , environmental tobacco smoke , cleanliness ,
rats, hamsters, birds, and cockroach. Heinrich et al.9
supported the correlation between higher endotoxin
levels in house dust from metropolitan homes with
cats or dogs but not other animals.
Rabinovitch et al. 10 measured personal exposures
to endotoxin in schoolchildren with asthma using
portable monitors that collect respirable particles ,
which were less than 10 μm in aerometric diameter.
Personal endotoxin exposures were associated with
the number of household inhabitants and the pres-
ence of pets. Alternatively, other studies found a lack
of association between endotoxin and pets.
Aside from the home, more recent studies have
highlighted contamination of endotoxin in metropoli-
tan public child-care facilities (i.e., daycare centers,
preschools, kindergartens, and elementary schools),
where children spend a lot of their time. Rullo et al.11
assessed endotoxin levels in house dust from metro-
politan public child-care facilities in Sao Paulo, and
showed that levels of endotoxin in daycare centers
and preschools were three times higher than in ele-
mentary schools. Consequently, daycare centers and
preschools may be important sources of exposure to
endotoxin in urban areas. Based on the hygiene hy-
pothesis, this finding provides an explanation for a
previous study12 that showed children, who attended
daycare within the first six months of life, were less
likely to have asthma and recurrent wheezing in later
childhood.
Since endotoxin can exacerbate allergy and asthma
symptoms , studies have been conducted to deter-
mine if frequent cleaning reduces endotoxin expo-
sure. Unfortunately, various cleaning techniques do
not appear to significantly reduce endotoxin expo-
sure . For example , reported cleaning frequency of
metropolitan homes or appearance of tidiness was
not associated with lower endotoxin levels.9 Dairy in-
dustrial cleaning practices in child-care facilities and
schools produced no difference in endotoxin levels in
the morning compared with after cleaning in the late
afternoon.12 On the other hand, less active forms of
environmental control can lower detectable endo-
toxin. Use of both a dehumidifier13 as well as air con-
ditioning in Denver homes was associated with lower
endotoxin levels.9 However, these studies did not de-
termined if reduced endotoxin levels were relevant to
the prevalence of atopic sensitization or symptoms.
REVIEW OF RECENT DEVELOPMENT IN
THE AREA OF EPIDEMIOLOGY
URBAN STUDIES
Public hygiene measures are well implemented in
modern metropolitan communities . However , an
atopy-protective effect of endotoxin in these clear
metropolitan environments still occurs.1,14 Gereda et
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OVA-specific 
IgG
(1/log2 titer)
OVA-specific 
IgE
 (1/log2 titer)
Lymphocytes
 (106/ml)
Eosinophils 
(106/ml)
Macrophages
 (106/ml)
Neutrophils 
(106/ml)
Evans blue 
dye (mg/ml)
Total count 
(106/m/)
Exposure　n
(d)
 4.32 ± 0.43 7.32 ± 0.29 0.18 ± 0.040 0.44 ± 0.02 0.02 ± 0.01 1.95 ± 0.02 0.64 ± 0.148Sens/saline
 4.15 ± 0.40 7.03 ± 0.35 2.15 ± 0.15＊ 0.16 ± 0.03＊ 1.59 ± 0.10＊ 0.26 ± 0.03＊ 4.36± 0.21＊ 4.16 ± 0.19＊11Sens/OVA
 10.16 ± 0.34++ 3.49 ± 0.52++ 0.27 ± 0.03++0++ 0.40 ± 0.08++ 0.08 ± 0.02++ 2.68 ± 0.76++ 0.75 ± 0.05++6LPS-1
 9.72 ± 0.57++ 3.92 ± 0.57++ 0.33 ± 0.07++0++ 0.49 ± 0.08++ 0.07 ± 0.02++ 2.88 ± 0.51++ 0.90 ± 0.13++5LPS1
 8.72 ± 0.91++ 2.92 ± 0.45++ 0.48 ± 0.15++0++ 0.49 ± 0.08++ 0.10 ± 0.03+ 3.31 ± 0.74++1.04 ± 0.20++5LPS2
 9.12 ± 1.19++ 4.52 ± 0.74++ 0.35 ± 0.17++0++ 0.50 ± 0.06++ 0.12 ± 0.02+ 2.88 ± 0.57++ 0.88 ± 0.20++5LPS4
 3.92 ± 0.55 7.32 ± 0.48 0.83 ± 0.23++ 0.43 ± 0.08++ 0.62 ± 0.10++ 6.48 ± 0.8++ 6.98 ± 0.34++ 8.36 ± 0.67++5LPS6
 2.92 ± 0.45 7.92 ± 0.67 0.88 ± 0.12++ 0.54 ± 0.18++ 0.74 ± 0.21++ 6.70 ± 0.51++ 6.23 ± 0.67++ 8.86 ± 0.52++5LPS8
 3.32 ± 0.50 8.32 ± 0.61 0.66 ± 0.18++ 0.60 ± 0.16++ 0.67 ± 0.22++ 6.23 ± 0.52++ 5.74 ± 0.38++ 8.16 ± 0.55++5LPS10
Inflammatory responses in ovalbumin (OVA)-sensitized and OVA-chalenged animals exposed to lipopolysaccharide (LPS) 24 h before 
sensitization (LPS-1 group) or 1, 2, 4, 6, 8 and 10 d after sensitization. Serum OVA-specific IgE and IgG were measured. Total and difer-
ential cel counts in the BALF and Evans blue dye leakage were studied (Ref. 42). Results are expressed as means ± SEM.
 ＊ P < 0.01 vs. sens/saline.
+P < 0.05, ++P < 0.01 vs. sens/OVA.
Table 1　Efects on inflammatory cel count, microvascular leakage, and serum antibody levels 
al.15 compared concentrations of endotoxin in house
dust with allergen sensitization in infants at a high
risk for developing asthma. The homes of allergen-
sensitized infants contained lower concentrations of
house dust endotoxin than those of non-sensitized in-
fants (mean 468 vs. 1,035 EUml). Increased house
dust endotoxin concentrations correlated with in-
creased populations of IFN-γ-producing CD4 T cells
(Fig. 2). Such concentrations did not correlate with
populations of cells that produced IL-4, 5, or 13. This
study may provide the first direct in vivo evidence
that indoor endotoxin exposure early in life may pro-
tect against allergen sensitization by enhancing Th1 -
type immunity. Gehring et al. 16 showed that in the
cross-sectional study of 740 children from eastern
Germany, between five and ten years of age, endo-
toxin levels were inversely associated with sensitiza-
tion to one or more allergens. This is the first study
to demonstrate an association of higher endotoxin ex-
posure from house dust with a lower prevalence of
atopic sensitization in children. On the other hand, Li-
tonjua et al.17 investigated the longitudinal effects of
exposure to house dust endotoxin on wheezing in
226 young children younger than five years over a
four-year period. Exposure to high concentrations of
house dust endotoxin of greater than the median
level (81.3 EUmg dust) was associated with an in-
creased risk for wheezing over the period of observa-
tion, but this risk rapidly decreased over time.
The results of the study by Bottcher et al.18 showed
that lower levels of atopic diseases at two years of age
were found in the population from Estonia where en-
dotoxin exposures were higher than in the compari-
son population from Sweden. However, the study has
some weakness. For example, only eight atopic chil-
dren were studied from Estonia, and different sam-
pling methods were used in the two populations .
Therefore, more studies of comparable populations,
including regional birth-cohort studies and interna-
tional comparative studies, are necessary. In addition,
other indoor factors , such as pollutants , allergens ,
toxins and social factors should also be investigated
to clarify a possible causal effect of the levels of endo-
toxin.19
FARMING STUDIES
The collaborative Allergy and Endotoxin Study Team
(ALEX) reported on the relationship between chil-
dren’s mattress levels of endotoxin at school age and
the occurrence of asthma and allergies . 20 Braun-
Fahrlander, a member of ALEX, reviewed epidemi-
ological studies examining the effect of bacterial ex-
posure on atopy and asthma in rural populations, as
follows.2 Greater endotoxin exposure was associated
with less allergen sensitization , hay fever , atopic
asthma, and atopic wheeze in a dose-dependent man-
ner. This effect was observed in addition to and inde-
pendent of the effect of first-year exposure to farm
characteristics 21 and was not restricted to farming
households. It was equally strong in children from
non-farming homes, indicating that even lower levels
of endotoxin, as encountered in non-farming environ-
ments, may favorably influence the risk of atopic dis-
eases in childhood. The association between mattress
endotoxin was also examined in relation to the cy-
tokine production profile of peripheral blood leuko-
cytes after activation of the immune system by stimu-
lation with endotoxin and staphylococcal enterotoxin
B. Greater endotoxin exposure was associated with
reduced production of TNF-α, IL-10, IL-12 and IFN-γ,
suggesting a general suppression of the capacity for
cytokine production in response to activation of the
innate immune system . Reduced responsiveness
upon repeated stimulation with endotoxin is a phe-
nomenon previously described in the literature as en-
dotoxin tolerance.22 In a subset of the ALEX study
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group population, the blood cells of farmers’ children
expressed higher amounts of CD14 and TLR2, which
are innate immune receptors for bacterial products
that include endotoxin.23 An increased expression of
CD14 as well as TLR2 was also observed in human
leukocytes after treatment with endotoxin in vitro,24
which suggests that the differences found in vivo be-
tween farmers’ and non-farmers’ children mirror dif-
ferent degrees of exposure to such bacteria or bacte-
rial components in the environment．
Unfortunately, there is still no proof to support the
premise that specifically endotoxin, of all the possible
microbiological exposures experienced by farming
children, was responsible for the protection afforded
against atopic sensitization . As in the occupational
setting, it could be that endotoxin is just one of a com-
plicated microbiological milieu responsible for the im-
mune response differences and that endotoxin is just
a convenient , measurable marker of the environ-
mental exposures experienced in these communi-
ties.19
ASSOCIATION OF ENDOTOXIN AND PETS WITH
ATOPIC DISEASES
The triad of endotoxin exposure, household pets, and
atopic diseases asthma in childhood has been ex-
tensively studied in recent years. A number of stud-
ies25-30 suggested that early pet exposure protected
against atopy and asthma development . Many sur-
veys showed a positive correlation between endo-
toxin and household pets.8-10,13,31 These results con-
sistently supported an association between endotoxin
and pets with a reduced risk for atopy and asthma de-
velopment ; however, no surveys demonstrate a clear
relationship.
Litonjua et al.17 showed that exposure to cat aller-
gen and the presence of a dog in the home, but not
necessarily household endotoxin, were both associ-
ated with a decreased risk for wheezing. The nega-
tive association between exposure to dogs and cat al-
lergen and wheezing appeared to be independent of
the effects of endotoxin and suggested that separate
mechanisms might mediate the effects of house dust
endotoxin exposure and pet exposure on the develop-
ing immune system. Bolte et al.32 indicated that endo-
toxin had the potential to promote the development of
Th1 cells, whereas cat allergen was associated with
increased proportions of Th2 cells and both Th1- and
Th2-like CD8+ cells.
Some epidemiological issues are relevant to inter-
preting the inverse correlation between pet exposure
and a subsequent risk of atopic sensitization and
asthma.33 In a birth cohort study of 4,089 two-month-
old infants,34 pet ownership was lower in families with
a parental history of atopic diseases. In another birth
cohort study,35 cat allergen exposure, as monitored
by levels found in the parental mattress, was lower in
families with atopic mothers . Thus , parents with
atopic diseases were likely to avoid owning pets and,
therefore, exposure to pets. Consequently, children,
who had pets, were less likely to be atopic on the ba-
sis of genetic predisposition. On the other hand, Cele-
don et al.36 performed a birth cohort study of 505 in-
fants who were two to three months of age and whose
parents had a history of atopy, and reported that ma-
ternal history of asthma was not associated with expo-
sure to a cat or dog in their household. These unex-
pected results suggested that some of the variables
(i.e., parent-reported history of asthma, allergic rhini-
tis, or eczema) might not be related to cat or dog al-
lergy. The choice of variables to measure pet allergy
in parents might also lead to different assessments of
the correlation between endotoxin exposure, house-
hold pets and subsequent risk of atopic sensitization
and diseases．
ANIMAL MODELS FOR PARADOXICAL EN-
DOTOXIN EFFECTS
Endotoxin is a potent proinflammatory substance that
activates various cells in the respiratory tract, includ-
ing epithelial cells, endothelial cells, polymorphonu-
clear leukocytes, macrophages, and mast cells after
inhalation. As a result, inhaled endotoxin produces in-
flammatory responses, remodeling in the respiratory
system, and hyperresponsiveness in the airway.37-41
On the other hand, as described above, endotoxin ex-
posure in early childhood may paradoxically protect
children from the subsequent development of atopy
and asthma in later life. Experimental animal studies
also suggest that the relationship between endotoxin
and atopic immune responses and diseases may be
complicated. Many parameters that include dose, tim-
ing of exposure, environmental cofactors, and genet-
ics are probably relevant to this reduced risk of in-
creased susceptibility to atopic responses.
PROTECTIVE EFFECTS OF TIMING OF ENDO-
TOXIN EXPOSURE ON ATOPY AND ASTHMA
In an IgE-sensitized rat model,42 Piebald-Virol-Glaxo
rats were exposed to a single dose of inhaled endo-
toxin 1 day prior to sensitization and 1, 2, 4, 6, 8, and
10 days after sensitization to ovalbumin (OVA). On
day 11, animals were exposed to aerosolized 1% OVA,
and 24 h later inflammatory cell influx and microvas-
cular leakage into bronchoalveolar lavage fluid
(BALF) were measured. Pretreatment with inhaled
endotoxin 1 day before and up to 4 days after OVA
sensitization protected against the development of
OVA-specific IgE and eosinophil and neutrophil in-
flux into BALF. However, endotoxin exposure 6, 8, or
10 days after OVA sensitization further exacerbated
the OVA-induced cellular influx and increased plasma
leakage with no effect on OVA-specific IgE levels (Ta-
ble 1). In addition, OVA-induced airway hyperrespon-
siveness to methacholine was abolished in an animal
group pretreated with inhaled endotoxin 1 day before
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Fig. 3　Efect of lipopolysaccharide (LPS, 20 μg/animal) 
administered subcutaneously 18 h or just (#) before an intra-
venous injection of Sephadex beads on an eosinophil count 
in the BALF from Sephadex-treated rats (upper panel). Ef-
fect of LPS (20 μg/animal) administered subcutaneously 18 
h before an inhalation of LPS (30 μg/ml, 30 min) on a neutro-
phil count in the BALF from LPS-exposed rats (lower panel). 
＊P < 0.01 vs. saline-pretreated and saline-chalenged ani-
mals (sham control). Results are expressed as means ± 
SEM (n = 5―6). 
NS: not significant.
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OVA sensitization. This study demonstrated that ex-
posure to endotoxin modified the development of
atopic sensitization and inflammation in vivo.
In an IgE-sensitized mouse model,43 Balbc mice
were systemically sensitized with OVA on days 1 and
14 and challenged with inhaled OVA on days 34 to 36.
Serum OVA-specific IgE level, OVA-specific Th2 cy-
tokine production by splenic mononuclear cells in vi-
tro, and differential cell counts in BALF were as-
sessed . Intraperitoneal administration of endotoxin
before OVA sensitization reduced OVA-specific IgE,
production of Th2 cytokines (IL-4 and IL-5) and ex-
tent of airway eosinophilia, as compared to sham pre-
treatment in OVA-sensitized mice. Nasal administra-
tion of endotoxin to sensitized mice before OVA chal-
lenge induced IFN-γ production by peribronchial
lymph node cells in vitro, which was associated with
reduced BALF eosinophilia. Interestingly, inhibitory
effects of endotoxin on allergen sensitization and
eosinophilic accumulation in BALF were inhibited by
administration of anti-IL-12 antibodies before endo-
toxin exposure. These results indicated that systemic
and local applications of endotoxin modulated sys-
temic and local Th1Th2 immune responses, prob-
ably in an IL-12-dependent mode. Most rodent mod-
els for atopic asthma consistently show that early ex-
posure to endotoxin prevented atopic diseases and
later exposures increased diseases．
Tulic et al.44 showed that co-administration of aller-
gen with endotoxin modified both the acute and late-
phase airway responses to the allergen, including an
earlier acute change in lung function and a dose-
dependent inhibition of late-phase responses to the al-
lergen. Piebald-Virol-Glaxo rats were sensitized with
OVA and 11 days later challenged with 1% OVA in the
presence and absence of endotoxin given in the same
nebulizer . Presence of endotoxin in the nebulizer
during OVA challenge decreased the time-to-peak re-
sponse for airway resistance and the late-phase air-
way hyperresponsiveness to methacholine , cellular
influx into BALF and airway microvascular leakage at
24 h．
Eosinophilic infiltration into BALF of Sephadex
(dextran) bead-treated animals are elicited via Th2
cytokines IL-4-, IL-5-, and IL-13-, eotaxin-, VCAM-1-,
and ICAM-1-mediated pathways,45-47 indicating that a
fundamental mechanism exists between eosinophilic
infiltration into the lungs of Sephadex bead-treated
and allergen-exposed animals . We used Sephadex
bead-treated Wistar rats and showed that eosinophilic
infiltration into BALF was remarkably reduced by en-
dotoxin administered subcutaneously (20 μganimal)
before 18 h Sephadex bead administration. However,
the same dose of endotoxin administered subcutane-
ously just before Sephadex bead treatment had no in-
hibitory effect on the airway response (Fig. 3,unpub-
lished data). On the other hand, the same dose of en-
dotoxin administered subcutaneously at the two dif-
ferent time-points had no effect on neutrophilic infil-
tration into BALF induced by nebulized endotoxin
(30 μgml, 30 min) in Wistar rats (Fig. 3). The poten-
tial protective effects of endotoxin in the two-phase
rat model of asthma 44 and Sephadex-induced lung
eosinophilia appear to be mediated principally via en-
hancement of Th1 function, thus providing feedback
inhibition of atopy-associated Th2 immunity.3
Gerhold et al.48 investigated whether repeated ex-
posure of infant mice to inhaled endotoxin inhibited
subsequent allergen-induced immune and inflamma-
tory responses. Infant Balbc mice were pre-exposed
to nebulized endotoxin three times weekly for the
first four weeks of life before systemic sensitization
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with OVA (days 1―14) and repeated airway challenge
(days 28―30) with OVA. Pre-exposed endotoxin be-
fore OVA sensitization failed to prevent production of
OVA-specific IgE, Th2-mediated immune responses
including IL-4 and IL-5 production by splenic mono-
nuclear cells in vitro, and eosinophilic infiltration into
BALF in OVA-sensitized mice. This study appears to
be in conflict with previous epidemiological and ani-
mal studies supporting the hygiene hypothesis. Lan-
genkamp et al.49 have recently shown that endotoxin-
induced IL-12 production by dendric cells was tran-
sient and exhausted dendric cells subsequently pref-
erentially induce Th 2 or non-polarized T-cell re-
sponses, which may provide an explanation for these
unexpected findings．
PROTECTIVE EFFECTS ENDOTOXIN DOSE ON
ATOPY AND ASTHMA
Lower doses of endotoxin prime macrophages to re-
lease TNF-α and IL-12, while higher doses prime
toxic radical productions (i.e., nitric oxide and its me-
tabolites).50,51 Therefore, Th1-promoting immune re-
sponses may occur at lower doses. Eisenbarth et al.52
reported that signaling of low doses of endotoxin
through TLR 4 was necessary to induce Th 2 re-
sponses to inhaled antigens in a mouse model of al-
lergic sensitization. The mechanism by which endo-
toxin signaling caused atopic sensitization involved
the activation of antigen-containing dendritic cells. In
contrast, inhalation of high doses of endotoxin with
allergen produced Th1 responses. These studies sug-
gested that the dose of endotoxin determined the
type of inflammatory response and provided a poten-
tial mechanistic explanation for epidemiological data
on endotoxin exposure and asthma prevalence．
CONCLUSION
The hygiene hypothesis implies that microbial stimu-
lation in early life skews the immune system towards
the development of a Th1-type lymphocyte population
and away from a Th2-type development that is associ-
ated with atopy. While epidemiological support for
this theory is increasing, a cause-and-effect relation-
ship between endotoxin exposure and a lower preva-
lence of atopy and asthma has not been proven ; per-
haps endotoxin is a marker for other microbial expo-
sures or environmental or lifestyle factors that are ac-
tually preventing disease onset . Therefore , further
prospective studies in different locales are necessary
to determine if endotoxin is actually responsible for
the atopy- and asthma-protective effect.1
Since atopy is caused by both environmental and
genetic factors, studies are needed to identify genetic
variants that affect endotoxin sensitivity. The interac-
tion of CD14 and endotoxin may represent the first
documented gene and environmental interaction in
the development of atopy and asthma.53 Variants in
the CD 14 gene are associated with atopy in different
populations all over the world.53 The polymorphisms
of TLR4 gene were associated with a modified re-
sponse to endotoxin, but the functional relationship
requires clarification.54,55 Prospective cohort studies
that measure the genotypes of CD14 and TLR4 genes
and environmental exposures at different time-points
in early life will enable us to better understand the in-
teraction of the environmental and genetic factors.53
Microbe-derived immune modulatory therapies are
currently undergoing clinical trials. The key parame-
ters of timing, dosage, environmental co-factors, and
genetics of endotoxin should be determined in order
to provide effective and safe endotoxin-derived inter-
ventions for atopic diseases and asthma．
The difference in the route of endotoxin exposure
has not been discussed in the present review , al-
though the route of the gut is already considered an
important route of exposure.
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